Mr. Aitken-Davies is a founding partner of Altaris with responsibility for sourcing, analyzing, executing and monitoring private equity transactions. Prior to the formation of Altaris, Mr. Aitken-Davies was at Merrill Lynch where he was a member of the firm’s private equity and healthcare investment banking groups. Mr. Aitken-Davies received a Masters in Molecular and Cellular Biochemistry from the University of Oxford and investigated the metabolism of bovine prion protein for his research dissertation.

Mr. Aitken-Davies is currently a board member of the following Altaris portfolio companies: Alterna, Classic Industries, Intermed-Penlon, M2S, OsoBio, Paramit, Sparta Systems and U.S. HealthWorks.

Email: george.aitken-davies@altariscap.com
Phone: 212-931-0230